Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
The Tablet is stocked at 183 licensed dispensaries across California, with the deepest coverage in San Diego, Sacramento, Los Angeles, San Jose, and La Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, The Tablet’s mix is fully concentrated in Capsules at 100.0% share, with category sales up 53.8% year over year and 7.8% month over month, while average price declined 19.3% YoY to $32.24. Within California Capsules, the brand holds rank 7, pairing a MoM sales uptick of 7.8% with a YoY gain of 53.8%, indicating volume-led growth despite price compression. The pattern implies deliberate scale-through-price strategy in a single-category focus, trading lower unit pricing for higher throughput to maintain rank 7 while expanding YoY.
The 100.0% reliance on Capsules combined with a 19.3% YoY price decrease and a 53.8% YoY sales increase suggests price elasticity is favorable, with the 7.8% MoM lift reinforcing short-cycle responsiveness. Holding rank 7 in California while prices fall indicates the brand is competing on accessibility rather than premium positioning, prioritizing share defense in Capsules over diversification. The implication is that maintaining a single-category footprint can sustain growth if price-driven volume continues to offset compression, but concentration risk remains high if rank 7 slips amid further price moves.
Competitive Landscape
The Tablet sits at #7 in CA Capsules in October 2026, unchanged from #7 year over year, with its peak rank also #7 in October 2026 and no three-month movement from #7, indicating a flat trajectory while rivals reshuffle around it; Emerald Bay Extracts climbed from #6 to #1 alongside a 171.8% YoY sales increase, while Level slid from #1 to #3 with a 43.1% YoY sales decline. Breez held #2 with a 19.3% YoY sales drop, and Buddies advanced from #5 to #4 on 27.7% YoY growth, contrasting with Kikoko moving from #4 to #5 amid a 21.1% YoY decline; this combination of rank stability at #7 and competitor volatility implies The Tablet is anchored in the lower top 10, and without a catalyst it is more likely to be leapfrogged by climbers than to gain share.
Notable Products
The Tablet’s October 2026 lineup is concentrated in two Sativa tablets that together account for 49.7% of sales, led by Sativa Tablets 20-Pack (1000mg) at 25.9%. With Capsules in Sativa and Indica totaling 87.0% of brand sales, most revenue comes from these core formats and strains, so most of its sales ride on Sativa and Indica capsules.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






